Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3817254 A
Publication typeGrant
Publication dateJun 18, 1974
Filing dateMay 8, 1972
Priority dateMay 8, 1972
Also published asCA1010508A1, DE2322953A1
Publication numberUS 3817254 A, US 3817254A, US-A-3817254, US3817254 A, US3817254A
InventorsD Maurer
Original AssigneeMedtronic Inc
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Transcutaneous stimulator and stimulation method
US 3817254 A
Abstract
A transcutaneous stimulator for stimulating portions of the body. The output of the stimulator is a stimulating pulse having frequency components falling within predetermined frequency band limits so as to optimally excite touch nerve fibres relative to nociceptor or pain receptor nerve fibres.
Images(1)
Previous page
Next page
Description  (OCR text may contain errors)

United States Patent 1191 Maurer June 18 1974 TRANSCUTANEOUS STIMULATOR AND 2,771,554 11/1956 Gratz 128/421 STIMULATION METHOD FOREIGN PATENTS OR APPLICATIONS [75] Inventor: Donald Mamr Anoka, 1,088,607 10/1967 Great Brita.in..... 123/1 c [73] Assignee: Medtronic, Inc., Minneapolis, Minn. V

Primary Examiner-William E. Kamm [22] May 1972 Attorney, Agent, or FirmLew Schwartz; Wayne A. [21] Appl. No.: 251,280 Sivemon [52] US. Cl. 128/421 57 ABSTRACT [51] Int. Cl A6ln 1/36 [58} Field of Search 128/1 0, 2.1 R, 419 c, A transcutaneous snmulator fi stlmulafimg PP 128/419 E 419 R 420 421 422 423 of the body. The output of the stlmulator 1s a Stnnulating pulse having frequency components falling within [56] References Cited predetermined frequency band limits so as tooptimally excite touch nerve fibres relative to nociceptor UNITED STATES PATENTS or pain receptor nerve fibres. 1,908,688 5/1933 Call 128/420 2,764,683 9/1956 Daust et al 128/423 8 Claims, 2 Drawing Figures 211251 f ,7 1 1 PULSE GENERATOR FILTER AND CURRENT T 12- CONTROL 1a PATENTEBJII 18 874 HSNOdSSH HALLVIEIHI TRANSCUTANEOUS STIMULA'IOR AND STIMULATION METHOD BACKGROUND OF THEINVENTION Peripheral nerve fibres have been classified in order of decreasing size and conduction velocity in a manner which is now standardized. Generally, as the fibre size decreases, the amplitude of electrical stimulation required to elicit an action potential increases. Also, the smaller fibre will require longer pulse durations than large fibre stimuli. These differences in nerve response have been used to selectively stimulate different types of nerve fibres by varying the amplitude, pulse duration, or pulse repetition rate of an electrical stimulating pulse. The desired degree of nerve fibre selectivity, however, has not been achieved in the prior art, with the result that, for example, an elicited touch response resulting from the stimulating pulse is often accompanied by a prickly, stinging, burning, sharp or other unpleasant noxious response.

SUMMARY OF THE INVENTION The present invention provides a stimulating pulse having frequency components falling within predeterters. The type of stimulation specified herein, optimizes the differential excitation between touch and pain specific fibres, thus optimizing the inhibition of pain transmission.

BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a block diagram of a transcutaneous stimulator embodying the present invention. l I

FIG. 2 is a graph of touch and pain response versus frequency. 1 1

DETAILED DESCRIPTION OF A PREFERRED EMBODIMENT There is an increasing interest in external electrical skin stimulation for such purposes as pain suppression, neuro-muscular stimulation, communication systems, etcetera. The preferred embodiment of the present invention as described herein, is directed particularly at a transcutaneous stimulator for the suppression of organic pain, although it has obvious applications beyond this particular field. In understanding the present invention, the prior art devices shown in US. Patent Nos. 1,059,090 and No. 1,305,725 should be mentioned. These devices, are essentially pulse generators which have the capacity to suppress organic pain when applied to the body in proper relation to the nervous system. Along with the organic pain suppression, however, there is a concurrent noxious sensation producedby the stimulation which, over a period of time, may become more distracting that the organic pain being suppressed. Prior art attempts to eliminate this noxious sensation have included variations in the pulse amplitude, pulse duration, and pulse repetition rate. To an extent, these approaches have provided some success v but, in their success, have limited the application of the technique by placing very restrictive parameters on its operation.

The present invention can best be understood by viewing the pulses used in the prior art devices in terms of a Fourier transform analysis. Any pulse has a fundamental sine wave component. Non-sine wave pulses, in addition, have sine wave components having frequencies which are multiples of the fundamental frequency. By determining which of these frequency components operate on which of the various nerve classifications, it is possible to generate a signal whose frequency components fall within predetermined frequency band limits, thus reducing the undesired noxious sensation. Peripheral nerve fibres have a standard classification in order of decreasing size and conduction velocity. Those of particular interest here are the class A-beta fibres which :subserve touch and the class C fibres which are specific for pain. In addition, it has been demonstrated that the differential excitation of the A- beta fibres with respect to the C fibres will inhibit the transmission of pain information from the class C wave pulse. The pulse generator 10 is provided with a pulse rate control 11 which operates in a known manner. The output of the pulse generator 10 is transmitted by line 12 to a low pass active filter which may be one of a number of known types. Dependent upon the output of the pulse generator 10, the low pass filter 13 will produce a full or half wave pulse of a single frequency or having a plurality of frequency components within the bonds to be described hereinafter. The filtered wave is passed from the filter 13 over the line 14 to a power amplifier and current control 15 whose output is coupled to the output electrodes 17 and 18 by a conventional transformer 20. Either or both of the electrodes which are directly attached to the body may be of a type disclosed in my copending application, Ser. No. 251,179 filed May 8, 1972;, for Electrode for Transcutaneous Stimulator. A feedback line'Zl is employed to introduce a constant current feature to the stimulator of the present invention. In addition, in some applications it may prove necessary to vary the pulse repetition rate to overcome nerve adaption. This can be accomplished by providing a ramp generator as an input to the pulse generator 10 in any known manner.

Referring now to FIG. 2, there is shown a plot of touch and pain response versus frequency. The touch response curve 23 is essentially a bellshaped curve which results from direct electrical stimulation. Curve 24 shows the pain response curve with segments A, B and C. Segments A and C result from secondary effects of the stimulation, such as, for example, chemical effects Segment B results from both the secondary effects and the effect of direct electrical stimulation. A greater differential excitation of touch nerve fibres over pain nerve fibres will inhibit the transmission of a pain signal from the pain fibres. Any specific frequency of stimulation which elicits a greater touch response than pain response will inhibit the pain transmission thereby eliminating any noxious sensation from the stimulation. An

3 example of such a frequency is indicated in FIG. 2 at X.

Similarly, any pulse having individual frequency components which collectively elicit a greater touch response than pain response will inhibit pain transmission and eliminate any noxious sensation from the stimulation.

l have discovered that a substantially pure sine wave pulse, either full or half wave, within the range of substantially 1,000-3 ,000 Hz produces a greater touch response than pain response thereby eliminating any noxious sensation. Similarly, a stimulation pulse having a plurality of frequency components and substantially 90 percent of its energy falling within the predetermined frequency band limits of substantially IOU-5,000 Hz with the fundamental frequency preferably within the range of substantially l,000-3,000 Hz will produce a greater touch response than pain response thereby eliminating any noxious sensations.

Obviously, many modifications and variations of the present invention are possible in light of the above teaching. Specifically, there are many alternative ways of generating the optimized waveforms disclosed herein which do not depart from the intended scope of the application. For example, a frequency synthesizer could be employed in place of the pulse generator and filter 13. Accordingly, it is to be understood that, within the scope of the appended claims, the invention may be practiced otherwise than as specifically described.

[ claim:

1. A stimulator adapted for use as a transcutaneous stimulator for the purpose of organic pain suppression which comprises:

pulse generator means;

filter means for transforming the pulses of the pulse generator means into output pulses each comprising a plurality of frequency components having substantially percent of their energy throughout substantially -5 ,000 Hz; and

output means connected to said filter means for applying said transformed pulses transcutaneously.

2. The stimulator of claim 1 wherein the transformed pulses are full cycle pulses.

3. The stimulator of claim 1 wherein the transformed pulses are half cycle pulses.

4. The stimulator of claim 1 wherein said output means further comprises constant current means for regulating the current output of said filter means.

- 5. A transcutaneous stimulator which comprises:

means for producing a series of pulses, each of said pulses having frequency components substantially 90 percent of the energy of which falls within substantially 100-5,000 Hz and output means connected to said pulse series producapplying the pulses to the portion of the body.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US1908688 *Jun 6, 1929May 16, 1933Gen Electric X Ray CorpElectrotherapeutic apparatus
US2764683 *Apr 18, 1952Sep 25, 1956Physical Medicine Products CoLow voltage electro-therapy generator
US2771554 *Apr 11, 1950Nov 20, 1956Gratzl KurtImpulse generator for medical use
GB1088607A * Title not available
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3902502 *Sep 13, 1974Sep 2, 1975Saul LissApparatus for temporarily arresting arthritic pain
US3911930 *Mar 1, 1974Oct 14, 1975Stimulation TechMethod and structure of preventing and treating ileus, and reducing acute pain by electrical pulse stimulation
US4068669 *Nov 24, 1975Jan 17, 1978Stimulation Technology, Inc.Stimulator fault protection circuit
US4121594 *Sep 26, 1977Oct 24, 1978Med General, Inc.Transcutaneous electrical nerve stimulator
US4167189 *Mar 28, 1977Sep 11, 1979Agency Of Industrial Science & TechnologyApparatus for transmission of information by electrocutaneous stimulus
US4249537 *May 18, 1979Feb 10, 1981Chaconas Charles GCurrent controlled muscle stimulator
US4305402 *Jun 29, 1979Dec 15, 1981Katims Jefferson JMethod for transcutaneous electrical stimulation
US4324253 *Mar 29, 1979Apr 13, 1982Greene Ronald WTranscutaneous pain control and/or muscle stimulating apparatus
US4340063 *Feb 14, 1980Jul 20, 1982Empi, Inc.Stimulation device
US4421336 *Sep 14, 1982Dec 20, 1983Wright State UniversityVehicle for the paralyzed
US4431002 *Jun 8, 1981Feb 14, 1984Empi Inc.Modulated deep afferent stimulator
US4442839 *Apr 27, 1981Apr 17, 1984Empi, Inc.Method of modulating energy in train of electrical pulses
US4480830 *Sep 14, 1982Nov 6, 1984Wright State UniversityMethod and apparatus for exercising
US4492233 *Sep 14, 1982Jan 8, 1985Wright State UniversityMethod and apparatus for providing feedback-controlled muscle stimulation
US4499900 *Nov 26, 1982Feb 19, 1985Wright State UniversitySystem and method for treating paralyzed persons
US4503863 *Sep 15, 1981Mar 12, 1985Katims Jefferson JMethod and apparatus for transcutaneous electrical stimulation
US4556214 *Aug 24, 1984Dec 3, 1985Wright State UniversityMethod and apparatus for exercising
US4917092 *Jul 13, 1988Apr 17, 1990Medical Designs, Inc.Transcutaneous nerve stimulator for treatment of sympathetic nerve dysfunction
US4919140 *Oct 14, 1988Apr 24, 1990Purdue Research FoundationMethod and apparatus for regenerating nerves
US5193537 *Jun 12, 1990Mar 16, 1993Zmd CorporationMethod and apparatus for transcutaneous electrical cardiac pacing
US5205284 *Jun 12, 1990Apr 27, 1993Zoll Medical CorporationMethod and apparatus for transcutaneous electrical cardiac pacing with background stimulation
US5282843 *Jan 9, 1992Feb 1, 1994Zmd CorporationElectrodes and method for transcutaneous cardiac pacing
US6205359Oct 26, 1998Mar 20, 2001Birinder Bob BovejaApparatus and method for adjunct (add-on) therapy of partial complex epilepsy, generalized epilepsy and involuntary movement disorders utilizing an external stimulator
US6208902Oct 26, 1998Mar 27, 2001Birinder Bob BovejaApparatus and method for adjunct (add-on) therapy for pain syndromes utilizing an implantable lead and an external stimulator
US6269270Oct 26, 1998Jul 31, 2001Birinder Bob BovejaApparatus and method for adjunct (add-on) therapy of Dementia and Alzheimer's disease utilizing an implantable lead and external stimulator
US6309406Nov 24, 1999Oct 30, 2001Hamit-Darwin-Fresh, Inc.Apparatus and method for inducing epileptic seizures in test animals for anticonvulsant drug screening
US6988005Apr 29, 2002Jan 17, 2006International Rehabilitative Sciences, Inc.Multi-functional portable electro-medical device
US7415309 *Jul 11, 2005Aug 19, 2008Boston Scientific Scimed, Inc.Percutaneous access for neuromodulation procedures
US7949403Feb 27, 2007May 24, 2011Accelerated Care Plus Corp.Electrical stimulation device and method for the treatment of neurological disorders
US8027718 *Mar 7, 2006Sep 27, 2011Mayo Foundation For Medical Education And ResearchRegional anesthetic
US8170675Sep 26, 2011May 1, 2012Nevro CorporationSelective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8209021Sep 26, 2011Jun 26, 2012Nevro CorporationSelective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8255057Jan 29, 2009Aug 28, 2012Nevro CorporationSystems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US8355792Apr 13, 2012Jan 15, 2013Nevro CorporationSelective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8359102Apr 13, 2012Jan 22, 2013Nevro CorporationSelective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8359103Apr 13, 2012Jan 22, 2013Nevro CorporationSelective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8396559Feb 16, 2012Mar 12, 2013Nevro CorporationSelective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8423147Sep 26, 2011Apr 16, 2013Nevro CorporationDevices for controlling high frequency spinal cord modulation for inhibiting pain, and associated systems and methods, including simplified controllers
US8428748Apr 13, 2012Apr 23, 2013Nevro CorporationSelective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8430805May 20, 2009Apr 30, 2013Emkinetics, Inc.Method and apparatus for magnetic induction therapy
US8435166May 20, 2009May 7, 2013Emkinetics, Inc.Method and apparatus for magnetic induction therapy
US8509905Apr 13, 2012Aug 13, 2013Nevro CorporationSelective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8509906Jul 9, 2012Aug 13, 2013Nevro CorporationSystems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US8554326Mar 14, 2013Oct 8, 2013Nevro CorporationSelective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8588884May 28, 2010Nov 19, 2013Emkinetics, Inc.Microneedle electrode
US8649874Nov 30, 2011Feb 11, 2014Nevro CorporationExtended pain relief via high frequency spinal cord modulation, and associated systems and methods
US8676330May 17, 2011Mar 18, 2014ElectroCore, LLCElectrical and magnetic stimulators used to treat migraine/sinus headache and comorbid disorders
US8676331Mar 14, 2013Mar 18, 2014Nevro CorporationDevices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection
US8694108Apr 22, 2010Apr 8, 2014Nevro CorporationDevices for controlling high frequency spinal cord modulation for inhibiting pain, and associated systems and methods, including simplified controllers
US8694109Dec 21, 2012Apr 8, 2014Nevro CorporationSelective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8712533Apr 22, 2010Apr 29, 2014Nevro CorporationSelective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8718781Dec 27, 2012May 6, 2014Nevro CorporationSelective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8718782Mar 14, 2013May 6, 2014Nevro CorporationSelective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8738142May 23, 2011May 27, 2014Accelerated Care Plus Corp.Electrical stimulation device and method for the treatment of neurological disorders
US8768472Dec 4, 2012Jul 1, 2014Nevro CorporationMulti-frequency neural treatments and associated systems and methods
US8774926Dec 4, 2012Jul 8, 2014Nevro CorporationMulti-frequency neural treatments and associated systems and methods
US8792988Sep 25, 2013Jul 29, 2014Nevro CorporationSelective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8798754Mar 10, 2008Aug 5, 2014Venturi Group, LlcNeural blocking therapy
US20110264002 *Dec 3, 2009Oct 27, 2011Koninklijke Philips Electronics N.V.Electrical stimulation device for locating an electrical stimulation point and method
US20130172957 *Dec 14, 2012Jul 4, 2013ElectroCore, LLC.Non-invasive nerve stimulator circuit
USRE40279Jun 26, 1997Apr 29, 2008Sherwood Services AgMethod and system for neural tissue modification
USRE41045Jun 12, 2003Dec 15, 2009Covidien AgMethod and apparatus for altering neural tissue function
EP0099662A1 *Jun 27, 1983Feb 1, 1984John Kenneth WilmotTranscutaneous electrical nerve stimulation apparatus
EP0103491A1 *Sep 14, 1983Mar 21, 1984Wright State UniversityMethod and apparatus for providing feedback-controlled muscle stimulation
EP0111229A2 *Nov 25, 1983Jun 20, 1984Neurotronic (1981) Ltee.Electric nerve stimulator device
WO1991019535A1 *Jun 12, 1991Dec 26, 1991Zmi CorpMethod and apparatus for transcutaneous cardiac pacing
Classifications
U.S. Classification607/46
International ClassificationA61N1/34, A61N1/36, A61N1/32
Cooperative ClassificationA61N1/36021
European ClassificationA61N1/36E4, A61N1/36E2